Maxeon (MAXN) Misses Q1 EPS by 15c

Maxeon (NASDAQ: MAXN) reported Q1 EPS of ($1.45), $0.15 worse than the analyst estimate of ($1.30). Revenue for the quarter came in at $223.08 million versus the consensus estimate of $213.03 million.

GUIDANCE:

Maxeon sees Q2 2022 revenue of $215-230 million, versus the consensus of $274 million.

For earnings history and earnings-related data on Maxeon (MAXN) click here.

You May Also Be Interested In

• AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
• Bank of America tops estimates as earnings rise 34%
• Bank of America (BAC) Tops Q2 EPS by 9c, Beats on Revenue